Endothelial Dysfunction As A Predictor Of Perioperative Outcome
1 other identifier
observational
90
1 country
1
Brief Summary
The goal of this clinical research study is to learn whether the inability of certain blood vessel cells (endothelial cells) to function properly may help researchers to predict who is at risk for complications after surgery and whether this dysfunction contributes to complications after surgery. This study will use a blood test to quantify the number of cells that are destined to become endothelial cells.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 5, 2006
CompletedFirst Posted
Study publicly available on registry
October 6, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2019
CompletedSeptember 24, 2019
September 1, 2019
13.3 years
October 5, 2006
September 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Patient Major Pulmonary Events (MPE)
Baseline (entry in study) to end of study (estimated 1 year post-operative)
Secondary Outcomes (1)
Patient's Duration of intensive care unit / hospital length of stay
Baseline to final day of hospitalization
Study Arms (1)
Endothelial Dysfunction
Participants are scheduled for major chest (lung or esophagus) surgery or are a healthy volunteer. A blood test will quantify the number of cells that are destined to become endothelial cells.
Eligibility Criteria
Study participants is scheduled to have major chest (lung or esophagus) surgery or is a healthy volunteer.
You may qualify if:
- Patients scheduled for major thoracic surgery (lobectomy, pneumonectomy, esophagectomy).
- Patients 18 years of age or older.
- Patients who have signed the consent form to participate in the study.
- Patients must have been evaluated in the Preanesthesia Clinic or by a staff Anesthesiologist preoperatively.
- All laboratory and diagnostic evaluations required or used to evaluate the patient in the Preanesthesia Clinic must be completed. All patients must be approved for surgery by the standards of the Preanesthesia Clinic.
You may not qualify if:
- Refusal to participate in the study.
- Patient is under age 18.
- Patient is unwilling to sign consent.
- Patient is unable to exercise (bedridden or wheel chair bound).
- Patient is enrolled in another study deemed by the investigator to affect oxygen metabolic efficiency and not presently the standard of care at MDACC.
- Any patient whose condition is deemed unsatisfactory for surgery after the preanesthetic evaluation.
- Surgery canceled for any reason. The patient may reenter the study if surgery is rescheduled.
- Patient has had a myocardial infarction within 3 months of visiting the Preanesthesia Clinic or presents with new or unstable angina.
- Patient has a history of cerebrovascular accident or transient ischemic attacks within 3 months of visiting the Preanesthesia Clinic.
- Patient has a history of pulmonary embolic event within 3 months of visiting the Preanesthesia Clinic.
- Patient known to have acute or chronic deep vein thrombosis.
- Pregnant patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
Biospecimen
Blood samples collected to measure number of circulating blood cells that become endothelial cells. During surgery a small sample of lung tissue collected, if available.
Study Officials
- PRINCIPAL INVESTIGATOR
Reza-John Mehran, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2006
First Posted
October 6, 2006
Study Start
March 1, 2006
Primary Completion
June 5, 2019
Study Completion
June 5, 2019
Last Updated
September 24, 2019
Record last verified: 2019-09